HOME >> MEDICINE >> NEWS
UQ Australian of the Year will continue to fight for women's health

Professor Ian Frazer will use his profile as Australian of the Year to help ensure his cancer vaccine reaches those who need it most women and girls living in poverty.

Professor Frazer, of The University of Queensland, is a humble recipient of the nation's top honour.

"It's a marvellous honour, especially as I follow in the footsteps of distinguished medical scientists who are recent Australians of the Year: Professor Peter Doherty, Sir Gus Nossal and Professor Fiona Wood," Professor Frazer said.

"Gus, Fiona and I all chose to be Australians and to make this country the cradle of research that aims to improve the lives of millions of people.

"It's a great privilege to be recognised by Australia as the 2006 Australian of the Year.

"But it's an even greater privilege to be able to do something tangible for the health of Australian women, and for women throughout the world," Professor Frazer said.

Professor Frazer and the late Dr Jian Zhou made a discovery at UQ more than 15 years ago that has led to the development of a vaccine for cervical cancer. The vaccine, known as Gardasil and Cervarix, is expected to become available in the developed world in mid-2006.

On Saturday (January 21) Professor Frazer was also named 2005 Australian of the Year by The Australian.

Professor Frazer said Australia and other developed nations had effective Pap smear programs to reduce the incidence of cervical cancer.

"Despite this, cervical cancer continues to be a shocking disease for women in the developed world.

"Women living in poverty in the developing world, where Pap smears are not widely available, account for most of the 275,000 deaths from cervical cancer each year.

"So this vaccine has the potential to do most good in the developing world, where it could help lift women out of poverty by relieving the burden of disease.

"Women in China, birthplace of my late colleague Dr Jian Zhou,
'"/>

Contact: Fiona Kennedy
61-733-651-088
Research Australia
25-Jan-2006


Page: 1 2

Related medicine news :

1. Federal Budget boosts Australian health and medical research
2. Young Australian scientist honored at international meeting
3. Australians support mandatory fitness testing to combat childhood obesity
4. Massive gun buyback doubled fall in Australian gun deaths
5. Australian researchers win $2 million
6. 10 top Australian scientists predict major medical advances
7. Cancer in the workforce: mapping the Australian experience
8. Unsung heroes recognised in 2006 Australian Nursing Awards
9. New research reveals Australians too busy for lunch
10. Startling new facts about what Australians are eating for lunch
11. Spirited study aims to help older Australians

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Australian the Year will continue fight for women health

(Date:5/24/2013)... The British Menopause Society and Women,s Health Concern have ... to provide clarity around the role of HRT, the ... the society,s flagship title, Menopause International , published ... HRT has changed from being branded the "elixir of ... be used in certain circumstances. Since the publication of ...
(Date:5/24/2013)... Today marks the launch of Destination ... , The redesigned and enhanced Itinerary Builder will ... on their computer or mobile device that they can ... allows users to fill in their date of arrival ... their choice of vacation packages, accommodations, restaurants, and things ...
(Date:5/24/2013)... Wixom, MI (PRWEB) May 24, 2013 ... recent Cute Baby Photo Contest. Lindsey Willis of Olathe, ... Cuties-brand diapers from DiaperBuys. Second prize was a ... Heather Tacher, North Las Vegas, Nev.; and third prize, ... Texas. , The contest was run through the company’s ...
(Date:5/24/2013)... 2013 Wednesday, 15th May 2013 | 10am ... to access webinar playback: http://bit.ly/10Rt0ZH , Ongoing regulatory ... markets. Across the globe and particularly in Europe, a number ... M&A activity . For dealmakers, understanding how the likes of ... Tax’ affects your corner of the market will give you ...
(Date:5/24/2013)... San Diego, CA (PRWEB) May 24, 2013 ... informing consumers today of the latest update involving ... Zithromax and Zmax SR (azithromycin) can allegedly ... Canadian Broadcasting Company reported on May 17, 2013* ... and Drug Administration in warning that Zithromax can ...
Breaking Medicine News(10 mins):Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2Health News:DiaperBuys.com Announces Photo Contest Winners 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4
(Date:5/24/2013)... YORK , May 24, 2013 In accordance ... Rules and Rule 14e-1 of the United States Exchange Act, ... its original offer for Elan Corporation (NYSE: ELN). ... Limited ("Royalty Pharma") made an offer for the entire of ... Corporation, plc ("Elan") (the "Original Offer").  On ...
(Date:5/23/2013)... , May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... been named the 2013 Life Science Firm of the Year ... (TCM).  Vanda was honored at the TCM,s 25 th ... , Maryland.  The Tech Awards Celebration recognizes the leaders and ... Maryland and the surrounding regions. ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
Cached News: